SCHEMBL166396

SCHEMBL166396

Cc1csc(CNC(=O)c2cccc(C(=O)O)c2)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 1/20 0.48
RAB9A P51151 4/20 0.48
NPC1 O15118 3/20 0.48
HSP90AA1 P07900 1/20 0.48
SLC5A7 Q9GZV3 1/20 0.47
GCK P35557 2/20 0.46
GRM5 P41594 1/20 0.46
ROCK2 O75116 1/20 0.46
GRK2 P25098 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.44
HPGD P15428 1/20 0.44
GAA P10253 1/20 0.44
KMT2A Q03164 1/20 0.44
HSD17B10 Q99714 1/20 0.44
NR1H4 Q96RI1 2/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
MMP13 P45452 1/20 0.44
EPHX2 P34913 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3507210 0.90 RAB9A (0.51) NAMPTRAB9ANPC1HSP90AA1SLC5A7
SCHEMBL3647405 0.89 ENPP2 (0.52) NAMPTRAB9ANPC1HSP90AA1SLC5A7
SCHEMBL3641653 0.89 NAMPT (0.48) NAMPTRAB9ANPC1HSP90AA1SLC5A7
SCHEMBL2711084 0.88 NPC1 (0.58) NAMPTRAB9ANPC1HSP90AA1SLC5A7
SCHEMBL166267 0.86 NAMPT (0.46) NAMPTRAB9ANPC1HSP90AA1SLC5A7
SCHEMBL26926866 0.82 ROCK2 (0.51) ROCK2GRK2GAANR1H4
SCHEMBL3686716 0.80 RAB9A (0.48) NAMPTRAB9ANPC1HSP90AA1SLC5A7
SCHEMBL2711113 0.79 NAMPT (0.47) NAMPTRAB9ANPC1HSP90AA1ROCK2
SCHEMBL2710128 0.78 NAMPT (0.46) NAMPTRAB9ANPC1HSP90AA1SLC5A7
SCHEMBL3510413 0.76 RAB9A (0.47) NAMPTRAB9ANPC1HSP90AA1SLC5A7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611441-A1 BACE INHIBITORS FOR USE IN THE TREATMENT OF DIABETES F.HOFFMANN-LA ROCHE AG (CH) 2013-07-10 EP disclosed
WO-2012028563-A1 BACE INHIBITORS FOR USE IN THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2012-03-08 WO disclosed